Smallpox Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Bavarian Nordic Announces Positive Results of Pivotal Phase 3 Study of Imvamune Smallpox Vaccine
COPENHAGEN, Denmark, February 6, 2018 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced positive results from a Phase 3 pivotal study of its investigational, non-replicating smallpox vaccine, Imvamune. The study achieved both of its... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 6, 2018 Category: Pharmaceuticals Source Type: clinical trials

IMVAMUNE ® Smallpox Vaccine in Adult Healthcare Personnel at Risk for Monkeypox in the Democratic Republic of the Congo
Condition:   Monkeypox Virus Infection Intervention:   Biological: IMVAMUNE® Sponsors:   Centers for Disease Control and Prevention;   Ministry of Public Health, Democratic Republic of the Congo;   Kinshasa School of Public Health;   Bavarian Nordic Not yet recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2016 Category: Research Source Type: clinical trials